Annual SGA
$16.68 M
+$511.00 K+3.16%
December 31, 2023
Summary
- As of February 22, 2025, CUE annual SGA is $16.68 million, with the most recent change of +$511.00 thousand (+3.16%) on December 31, 2023.
- During the last 3 years, CUE annual SGA has risen by +$2.03 million (+13.85%).
- CUE annual SGA is now -3.62% below its all-time high of $17.31 million, reached on December 31, 2021.
Performance
CUE SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly SGA
$2.87 M
-$644.00 K-18.34%
September 30, 2024
Summary
- As of February 22, 2025, CUE quarterly SGA is $2.87 million, with the most recent change of -$644.00 thousand (-18.34%) on September 30, 2024.
- Over the past year, CUE quarterly SGA has dropped by -$644.00 thousand (-18.34%).
- CUE quarterly SGA is now -44.39% below its all-time high of $5.16 million, reached on March 31, 2022.
Performance
CUE Quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM SGA
-$1.27 B
-$44.61 M-3.64%
September 30, 2024
Summary
- As of February 22, 2025, CUE TTM SGA is -$1.27 billion, with the most recent change of -$44.61 million (-3.64%) on September 30, 2024.
- Over the past year, CUE TTM SGA has dropped by -$1.29 billion (-8066.92%).
- CUE TTM SGA is now -13155.48% below its all-time high of -$9.59 million.
Performance
CUE TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Selling, General & Administrative Expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
CUE Selling, General & Administrative Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +3.2% | -18.3% | -8066.9% |
| 3 y3 years | +13.8% | -22.6% | -7959.0% |
| 5 y5 years | +47.7% | -22.6% | -7959.0% |
CUE Selling, General & Administrative Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -3.6% | +3.2% | -44.4% | at low | -74.5% | at low |
| 5 y | 5-year | -3.6% | +30.9% | -44.4% | at low | -231.2% | at low |
| alltime | all time | -3.6% | +3823.8% | -44.4% | +359.3% | <-9999.0% | at low |
Cue Biopharma Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $2.87 M(-18.3%) | $15.17 M(-4.9%) |
| Jun 2024 | - | $3.51 M(-16.1%) | $15.95 M(-4.4%) |
| Mar 2024 | - | $4.19 M(-9.2%) | $16.69 M(+0.1%) |
| Dec 2023 | $16.68 M(+3.2%) | $4.61 M(+26.4%) | $16.68 M(+5.7%) |
| Sep 2023 | - | $3.65 M(-14.2%) | $15.77 M(+0.7%) |
| Jun 2023 | - | $4.25 M(+1.7%) | $15.66 M(+3.1%) |
| Mar 2023 | - | $4.18 M(+12.7%) | $15.19 M(-6.1%) |
| Dec 2022 | $16.17 M(-6.6%) | $3.70 M(+5.0%) | $16.17 M(-5.5%) |
| Sep 2022 | - | $3.53 M(-6.7%) | $17.11 M(-3.4%) |
| Jun 2022 | - | $3.78 M(-26.6%) | $17.71 M(-2.7%) |
| Mar 2022 | - | $5.16 M(+11.0%) | $18.21 M(+5.2%) |
| Dec 2021 | $17.31 M(+18.1%) | $4.65 M(+12.6%) | $17.31 M(+7.0%) |
| Sep 2021 | - | $4.13 M(-3.6%) | $16.18 M(+5.4%) |
| Jun 2021 | - | $4.28 M(+0.6%) | $15.35 M(+2.6%) |
| Mar 2021 | - | $4.25 M(+20.8%) | $14.97 M(+1.8%) |
| Dec 2020 | $14.65 M | $3.52 M(+6.9%) | $14.70 M(+2.5%) |
| Sep 2020 | - | $3.29 M(-15.5%) | $14.34 M(+3.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2020 | - | $3.90 M(-2.3%) | $13.80 M(+3.1%) |
| Mar 2020 | - | $3.99 M(+26.2%) | $13.39 M(+4.2%) |
| Dec 2019 | $12.74 M(+12.8%) | $3.16 M(+14.8%) | $12.84 M(-9.3%) |
| Sep 2019 | - | $2.75 M(-21.0%) | $14.16 M(-1.0%) |
| Jun 2019 | - | $3.49 M(+1.2%) | $14.30 M(+9.6%) |
| Mar 2019 | - | $3.44 M(-23.0%) | $13.04 M(+15.4%) |
| Dec 2018 | $11.30 M(+160.6%) | $4.47 M(+54.5%) | $11.30 M(+37.0%) |
| Sep 2018 | - | $2.90 M(+29.8%) | $8.25 M(+29.2%) |
| Jun 2018 | - | $2.23 M(+30.9%) | $6.38 M(+24.0%) |
| Mar 2018 | - | $1.70 M(+20.0%) | $5.15 M(+18.8%) |
| Dec 2017 | $4.33 M(+119.9%) | $1.42 M(+37.8%) | $4.33 M(+17.4%) |
| Sep 2017 | - | $1.03 M(+3.4%) | $3.69 M(+12.3%) |
| Jun 2017 | - | $996.00 K(+12.0%) | $3.29 M(+43.5%) |
| Mar 2017 | - | $889.00 K(+14.4%) | $2.29 M(+63.4%) |
| Dec 2016 | $1.97 M(+363.5%) | $777.00 K(+24.5%) | $1.40 M(+124.5%) |
| Sep 2016 | - | $624.20 K | $624.20 K |
| Dec 2015 | $425.10 K | - | - |
FAQ
- What is Cue Biopharma annual SGA?
- What is the all time high annual SGA for Cue Biopharma?
- What is Cue Biopharma annual SGA year-on-year change?
- What is Cue Biopharma quarterly SGA?
- What is the all time high quarterly SGA for Cue Biopharma?
- What is Cue Biopharma quarterly SGA year-on-year change?
- What is Cue Biopharma TTM SGA?
- What is the all time high TTM SGA for Cue Biopharma?
- What is Cue Biopharma TTM SGA year-on-year change?
What is Cue Biopharma annual SGA?
The current annual SGA of CUE is $16.68 M
What is the all time high annual SGA for Cue Biopharma?
Cue Biopharma all-time high annual SGA is $17.31 M
What is Cue Biopharma annual SGA year-on-year change?
Over the past year, CUE annual SGA has changed by +$511.00 K (+3.16%)
What is Cue Biopharma quarterly SGA?
The current quarterly SGA of CUE is $2.87 M
What is the all time high quarterly SGA for Cue Biopharma?
Cue Biopharma all-time high quarterly SGA is $5.16 M
What is Cue Biopharma quarterly SGA year-on-year change?
Over the past year, CUE quarterly SGA has changed by -$644.00 K (-18.34%)
What is Cue Biopharma TTM SGA?
The current TTM SGA of CUE is -$1.27 B
What is the all time high TTM SGA for Cue Biopharma?
Cue Biopharma all-time high TTM SGA is -$9.59 M
What is Cue Biopharma TTM SGA year-on-year change?
Over the past year, CUE TTM SGA has changed by -$1.29 B (-8066.92%)